Literature DB >> 7471464

Methotrexate in the treatment of rheumatoid arthritis; pilot study.

W S Wilke, L H Calabrese, A L Scherbel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7471464     DOI: 10.3949/ccjm.47.4.305

Source DB:  PubMed          Journal:  Cleve Clin Q        ISSN: 0009-8787


× No keyword cloud information.
  10 in total

Review 1.  Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis.

Authors:  M Cutolo; A Sulli; C Pizzorni; B Seriolo; R H Straub
Journal:  Ann Rheum Dis       Date:  2001-08       Impact factor: 19.103

2.  Effect of vehicles and penetration enhancers on the in vitro and in vivo percutaneous absorption of methotrexate and edatrexate through hairless mouse skin.

Authors:  D J Chatterjee; W Y Li; R T Koda
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

3.  Response to methotrexate predicts long-term patient-related outcomes in rheumatoid arthritis.

Authors:  Dietmar Krause; Bernadette Gabriel; Gertraud Herborn; Juergen Braun; Rolf Rau
Journal:  Clin Rheumatol       Date:  2016-02-26       Impact factor: 2.980

Review 4.  [Methotrexate].

Authors:  R Rau
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

5.  Methotrexate therapy in rheumatoid arthritis. Current status.

Authors:  W S Wilke; A H Mackenzie
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

6.  Low-dose methotrexate treatment of rheumatoid arthritis; long-term observation of efficacy and safety.

Authors:  E Szanto
Journal:  Clin Rheumatol       Date:  1989-09       Impact factor: 2.980

Review 7.  Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis.

Authors:  Michael T Nurmohamed; Ben A C Dijkmans
Journal:  Drugs       Date:  2005       Impact factor: 9.546

8.  [Methotrexate in rheumatology].

Authors:  C Fiehn
Journal:  Z Rheumatol       Date:  2009-11       Impact factor: 1.372

Review 9.  Methotrexate intolerance in elderly patients with rheumatoid arthritis: what are the alternatives?

Authors:  Alexandros Drosos
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 10.  Disease-modifying antirheumatic drugs. Potential effects in older patients.

Authors:  G Gardner; D E Furst
Journal:  Drugs Aging       Date:  1995-12       Impact factor: 3.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.